SurModics Reports Third Quarter Fiscal Year 2012 Results
16:01 EDT 1 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
SurModics, Inc. (Nasdaq:SRDX), a leading provider of surface
modification and in vitro diagnostic technologies to the healthcare
industries, today announced results for its fiscal 2012 third quarter.
“We are pleased t...
Other Sources for this Article
SurModics, Inc.
Tim Arens, 952-500-7000
Vice President of
Finance and interim Chief Financial Officer
More From BioPortfolio on "SurModics Reports Third Quarter Fiscal Year 2012 Results"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
